• Saudi Arabia-based healthtech Madeed has secured additional pre-seed funding, bringing its total raised to $925,000.
• The round included SEEDRA Ventures, Unity Investment Partners, and Seen Growth, alongside earlier investors such as Vision Ventures and Saudi angels.
• Founded in 2025 by Adam Bataineh, the startup is building a preventive health platform focused on early disease risk detection through advanced biomarkers and laboratory testing.
• The funding will support product development and expansion of clinical and lab partnerships, starting in Saudi Arabia.
• In January, Vision Ventures led Madeed's $400,000 pre-seed round, with participation from Saudi angel investors Mashhoor Aldubayan, Mazen Aldarrab, and Abdulla Nadeem Elyas.

Press release:

Madeed, a Saudi platform specialising in preventative personalised healthcare, has secured additional pre-seed funding from SEEDRA Ventures, Unity Investment Partners, and Seen Growth. This funding is part of the investment round previously announced by the platform, which also included Vision Ventures and a group of Saudi investors, including Mashhour Al-Dubayan, Mazen Al-Darrab, and Abdullah Elias. 

The total funding now stands at $925,000. The initial funding will be used to develop the platform's products and expand clinical and laboratory partnerships in the region, with an initial focus on the Saudi market. This additional funding is expected to accelerate the platform's growth and enable it to launch its services more broadly in Saudi Arabia. 

These entities are among the most prominent investors actively supporting innovation and entrepreneurship in the region. SEEDRA Ventures, a Riyadh-based Saudi venture capital firm, focuses on supporting local entrepreneurs and early-stage startups, enabling them to contribute directly and positively to economic development. Unity Investment Partners, a private equity firm, supports a select group of global founders developing impactful solutions that shape the future. Seen Growth is an investment company specialising in private equity and venture capital, collaborating with high-potential companies and founders to support their growth journey and help them achieve sustainable, long-term value. 

Commenting on this initiative, Dr. Adam Batayneh, founder and CEO of Madeed, said, "We are proud of the partnerships we are building with a select group of organisations and companies, reflecting a high level of awareness regarding the importance of preventative healthcare and a commitment to improving the health and quality of life of individuals in our communities." He added, “We dedicated the past period to conducting the necessary operational tests on the platform to ensure its efficiency, smooth operation, and the integration of the services offered. We are optimistic about the results achieved so far, having attracted 150 subscribers during the pilot phase, which we consider a clear indicator of the expected demand upon the official launch.” 

Medeed is the first platform of its kind in the Middle East, specialising in personalised health services, preventative healthcare, and longevity. The platform adopts a proactive approach to disease prevention by utilising advanced laboratory data and artificial intelligence to identify early risk indicators for hundreds of diseases before symptoms appear. The platform also provides accurate, personalised health recommendations that align with each subscriber's needs and lifestyle and develops customised health plans and nutritional supplements to help subscribers achieve a healthy lifestyle thoughtfully and sustainably.